IDENTIFYING TARGETS FOR THERAPEUTICS USING PROTEOMICS TECHNOLOGY

Information

• Research Project
• 7946952

• ApplicationId

  7946952

• Core Project Number

  N01AI40057-9-0-1

• Full Project Number

  N01AI40057-9-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  6/30/2004 - 20 years ago

• Project End Date

  6/29/2009 - 15 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2009

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Myriad Genetics, Inc.

The objective of the Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology is to characterize pathogen and/or host cell proteomes to identify proteins associated with the biology of microbes, mechanisms of microbial pathogenesis, innate and adaptive immune responses to infectious agents, and/or non-immune mediated host responses that contribute to microbial pathogenesis. The data and reagents generated as a result of these analyses are being made available to the scientific community to stimulate the development of novel therapeutics, diagnostics and vaccines.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  153056

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:153056\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  MYRIAD GENETICS, INC.

• Organization Department

• Organization DUNS

• Organization City

  SALT LAKE CITY

• Organization State

  UT

• Organization Country

  UNITED STATES

• Organization Zip Code

  84108

• Organization District

  UNITED STATES